По вашему запросу найдено документов: 652

Страница 2 из 66

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
Kristeleit, Rebecca, Lisyanskaya, Alla, Fedenko, Alexander, Dvorkin, Mikhail, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Oza, Amit M (2022)
hospitals and cancer centres across 12 countries (Brazil, Canada, Czech Republic, Hungary, Israel, Italy
LONG-ACTING C-TERMINAL PEPTIDE-MODIFIED HGH (MOD-4023): RESULTS OF A SAFETY AND DOSE-FINDING STUDY IN GHD CHILDREN
Zelinska, N., Iotova, V., Skorodok, J., Malievsky, O., Peterkova, V., Samsonova, L., Rosenfeld, Ron G., Zadik, Zvi, Jaron-Mendelson, Michal, Koren, Ronit, Amitzi, Leanne, Raduk, Dmitri, Hershkovitz, Oren, Hart, Gili (2017)
Context: Daily injections are required for growth hormone (GH) replacement therapy, which may cause
An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
Zadik, Zvi, Zelinska, Nataliya, Iotova, Violeta, Skorodok, Yulia, Malievsky, Oleg, Mauras, Nelly, Valluri, Srinivas Rao, Pastrak, Aleksandra, Rosenfeld, Ron (2023)
. once-daily GH (Genotropin®) was initiated, after which participants could enroll into an open
ПЕРВЫЕ РЕЗУЛЬТАТЫ УЧАСТИЯ В ПИЛОТНОМ ПРОЕКТЕ МИНЗДРАВА РОССИИ ПО ДИСТАНЦИОННОМУ МОНИТОРИРОВАНИЮ АРТЕРИАЛЬНОГО ДАВЛЕНИЯ
EXPERIENCE OF PARTICIPATION IN THE BLOOD PRESSURE TELEMONITORING PILOT PROJECT OF THE MINISTRY OF HEALTHCARE
ХАСБИЕВ, С.А., АЛЛАЯРОВА, Р.М., ЗАГИДУЛЛИН, Н.Ш., ПЕТРОВА, Е.А., ВОЛКОВА, Р.В., МУДАРИСОВ, Д.Ф., KHASBIEV, S.A., ALLAYAROVA, R.M., ZAGIDULLIN, N.SH., PETROVA, E.A., VOLKOVA, R.V., MUDARISOV, D.F. (2021)
Значение исследования напряжения кислорода в моче в характеристике острого повреждения почек у больных коронавирусной инфекцией COVID-19
The significance of the study of oxygen tension in urine during of acute kidney injury in patients with COVID-19
Sarksyan, Denis S., Dudarev, Mikhail V., Yamoldinov, Nail R., Malinin, Oleg V., Anikaev, Vyacheslav P., Maleev, Viktor V., Akhtarova, Lyaysan R., Malov, Valery A., Сарксян, Д.С., Дударев, М.В., Ямолдинов, Н.Р., Малинин, О.В., Аникаев, В.П., Малеев, В.В., Ахтарова, Л.Р., Малов, В.А. (2023)
О механизме фармакологической регуляции неоиннервации в субхондральной кости хондроитин сульфатом на поздних стадиях остеоартрита
On the mechanism of pharmacological regulation of neoinnervation in the subchondral bone by chondroitin sulfate at late stages of osteoarthritis
Minasov, Timur B., Sarvilina, Irina V., Gromova, Olga A., Nazarenko, Anton G., Zagorodniy, Nikolay V., Минасов, Т.Б., Сарвилина, И.В., Громова, О.А., Назаренко, А.Г., Загородний, Н.В. (2025)
The primary hyperparathyroidism and its complications: Substantiation of funding volume for hospital pharmacotherapy
Zakharova, Oksana, Lobuteva, Alisa, Gribova, Yanina, Krylova, Olga, Mironenkova, Zhanna, Gabdulkhakova, Laysan, Belyavskiy, Maksim (2024)
hyperparathyroidism (PHPT) in a hospital setting to optimize therapeutic strategies and rationalize financing
ОСОБЕННОСТИ ФИЗИЧЕСКОГО РАЗВИТИЯ ШКОЛЬНИКОВ И СТУДЕНТОВ, ЗАНИМАЮЩИХСЯ ФИЗКУЛЬТУРОЙ И СПОРТОМ
FEATURES OF PHYSICAL DEVELOPMENT OF SCHOOLCHILDREN AND STUDENTS ENGAGED IN PHYSICAL EDUCATION AND SPORTS
АГАФОНОВ, А.И., ЗУЛЬКАРНАЕВ, Т.Р., ПОВАРГО, Е.А., СТЕПАНОВ, Е.Г., АХМЕТШИНА, Р.А., ХУСАИНОВ, А.Э., Agafonov, A. I., Zulkarnaev, T.R., Povargo, E.A., Stepanov, E.G., Akhmetshina, R.A., Khusainov, A.E. (2020)
DAILY ROUTINE
12-Month Effects of Once-Weekly and Twice-Monthly Administration of Hybrid Fc-Fused Human Growth Hormone, GX-H9, Treatment in Pediatric with GHD Deficiency
Malieyskiy, O., Mykola, A., Nataliya, Z., Bolshova, E.V., Senatorova, G., Oroszlan, G., Skorodok, J., Peterkova, V., Nataliya, C., Sorokman, T., Yang, S., Lee, J.E., Muzsnai, A., Hwang, J.S., Lee, S.Y., Choi, Y.J., Ji, H.J., Woo, J., Sung, Y.C. (2018)
daily of Genotropin® for up to 24 months. Among fifty-six pediatric GH naïve GHD subjects randomized
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
Santomauro, DF, Herrera, AMM, Shadid, J, Zheng, P, Ashbaugh, C, Pigott, DM, Abbafati, C, Adolph, C, Amlag, JO, Aravkin, AY, Bang-Jensen, BL, Idrisov, B, Group Author (2021)
, daily SARS-CoV-2 infection rate, and daily excess mortality rate). We then used this model to estimate

Страница 2 из 66

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год